Antidepressive agents
Showing 1 - 25 of 5,482
Falls in Older Adults: Analysis of World Health Organization
Completed
- Antidepressants Causing Adverse Effects in Therapeutic Use
- Fall
- Antidepressive Agents
-
Caen, Normandie, FranceCaen University Hospital, Department of Pharmacology
Nov 24, 2022
Depressive Disorder, Major, Treatment Outcome, Cognitive Dysfunction Trial in Copenhagen (Treatment Package for First-Episode
Recruiting
- Depressive Disorder, Major
- +4 more
- Treatment Package for First-Episode Depression
-
Copenhagen, DenmarkNeurobiology Research Unit, Rigshospitalet
Nov 12, 2022
Molecular Mechanisms of Pharmacological Action, Depression, Depressive Disorder Trial in Oxford (Prucalopride, Placebo)
Completed
- Molecular Mechanisms of Pharmacological Action
- +6 more
- Prucalopride
- Placebo
-
Oxford, United KingdomUniversity of Oxford
Nov 14, 2022
Deprescriptions, Antidepressive Agents, Antipsychotic Agents Trial in Bielefeld, Munich, Witten (PARTNER intervention, Control
Recruiting
- Deprescriptions
- +5 more
- PARTNER intervention
- Control intervention
-
Bielefeld, Germany
- +2 more
Apr 24, 2023
Prescription of Antidepressants and Delirium in Elderly :
Active, not recruiting
- Antidepressive Agents
- +2 more
-
Caen, Normandie, FranceCaen University Hospital, Department of Pharmacology
Apr 29, 2022
Dementia, Deprescriptions, Antidepressive Agents Trial in Copenhagen (Teaching material, Pre-visit reflection tool, Dialogue
Active, not recruiting
- Dementia
- +3 more
- Teaching material
- +4 more
-
Copenhagen, DenmarkUniversity of Copenhagen, department of Public Health, section o
Feb 23, 2022
Quality of Life, Antidepressive Agents, Depression, Anxiety Trial in Alicante (PLX)
Active, not recruiting
- Quality of Life
- +5 more
- PLX
-
Alicante, SpainUniversity of Alicante
Nov 19, 2021
Serum Concentrations of Antidepressant Drugs in Pregnant Women
Completed
- Pharmacokinetics
- +2 more
- sertraline, mirtazapine, venlafaxine, citalopram, escitalopram
-
Linköping, SwedenLinköping University
Mar 17, 2021
Depression, Depressive Disorder, Mental Disorder Trial in Oxford (Citalopram, Placebo)
Unknown status
- Depression
- +5 more
- Citalopram
- Placebo
-
Oxford, United KingdomUniversity of Oxford
Nov 13, 2019
Molecular Mechanisms of Pharmacological Action, Depression, Depressive Disorder Trial in Oxford (Citalopram, Placebo oral
Unknown status
- Molecular Mechanisms of Pharmacological Action
- +5 more
- Citalopram
- Placebo oral tablet
-
Oxford, United KingdomUniversity of Oxford
Nov 18, 2019
15 Different Antidepressants in Major Depressive Disorder
Completed
- Major Depressive Disorder
-
Copenhagen, DenmarkPsychiatric Center Copenhagen
Jul 18, 2023
Molecular Mechanisms of Pharmacological Action, Depression, Depressive Disorder Trial in Oxford (Prucalopride, Placebo)
Completed
- Molecular Mechanisms of Pharmacological Action
- +6 more
- Prucalopride
- Placebo
-
Oxford, United KingdomUniversity of Oxford
Mar 1, 2019
Social Anxiety, Depression Trial in Marburg (Active Placebo labelled as antidepressant)
Active, not recruiting
- Social Anxiety
- Depression
- Active Placebo labelled as antidepressant
-
Marburg, GermanyPhilipps-Universität Marburg
Jan 30, 2023
Risk Factors for AD-Associated Switch to Mania
Completed
- Bipolar Disorder
- Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor( SNRI), and Tricyclics.
-
Barcelona, Catalonia, SpainHospital Clinic Barcelona
Nov 17, 2021
Cognitive Burden and Neurobiological Homeostasis in Late-Life
Recruiting
- Depression in Old Age
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Apr 11, 2022
Depression, Depressive Disorder Trial in Bhopal (Healthy Activity Program (HAP), Antidepressant medication (ADM))
Recruiting
- Depression
- Depressive Disorder
- Healthy Activity Program (HAP)
- Antidepressant medication (ADM)
-
Bhopal, Madhya Pradesh, IndiaSangath
Nov 22, 2023
Headache Trial in Trondheim (Betablockers or other preventive drugs based on primary headache type)
Completed
- Headache
- Betablockers or other preventive drugs based on primary headache type
-
Trondheim, NorwayKnut Hagen
Dec 28, 2021
Polycystic Ovary Syndrome Trial in Odense (Escitalopram 20 mg, Placebo)
Completed
- Polycystic Ovary Syndrome
- Escitalopram 20 mg
- Placebo
-
Odense, DenmarkOdense Universitetshospital
Apr 24, 2023
Depressive Disorder, MDD, Depressive Episode Trial in Korea, Republic of (OMNIFIT DTx-MDD, standard treatment)
Not yet recruiting
- Depressive Disorder
- +2 more
- OMNIFIT DTx-MDD
- standard treatment
-
Ilsan, Korea, Republic of
- +4 more
Jan 25, 2023
MDD Trial in Gwangju (stepwise pharamacotherapy, antidepressant monotherapy group)
Recruiting
- Major Depressive Disorder
- stepwise pharamacotherapy
- antidepressant monotherapy group
-
Gwangju, Korea, Republic ofChonnam National University Hospital
Sep 19, 2023
Depression Trial in Xi'an (iTBS combined with antidepressants)
Enrolling by invitation
- Depression
- iTBS combined with antidepressants
-
Xi'an, Shaanxi, ChinaXijingH
Oct 9, 2022
Epilepsy Trial in Shanghai (psychology therapy)
Active, not recruiting
- Epilepsy
- psychology therapy
-
Shanghai, Shanghai, ChinaDepartment of Neurology, Zhongshan Hospital, Fudan University, S
Dec 19, 2021
Depression, Medication Adherence Trial in Beijing (antidepressant treatment, antidepressant treatment combined with
Recruiting
- Depression
- Medication Adherence
- antidepressant treatment
- antidepressant treatment combined with Internet-based interventions
-
Beijing, ChinaYunai Su
Sep 21, 2021
Treatment Resistant Depression Trial in Louisville (Discontinuation of serotonergic antidepressants, Continuation of
Recruiting
- Treatment Resistant Depression
- Discontinuation of serotonergic antidepressants
- Continuation of serotonergic medications
-
Louisville, KentuckyUniversity of Louisville, Department of Psychiatry and Behaviora
May 21, 2022